HIGHLIGHTS
- who: Florian Kahles from the University of Massachusetts Lowell, United States have published the research work: Gut immune cellsu2014A novel therapeutical target for cardiovascular disease?, in the Journal: (JOURNAL)
- what: Cardiometabolic diseases are characterized and driven by systemic inflammation.
- how: In this trial canakinumab was associated with a higher incidence of fatal infection compared to placebo.
SUMMARY
Scientific discoveries, advances in public health and innovations in medical care (including modern heart failure, lipid-lowering, and antiplatelet therapies) have contributed to a steady decline of mortality from cardiovascular disease in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.